Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Administering specialized lipids prevents memory loss, inflammation in Down syndrome mouse model

Administering specialized lipids prevents memory loss, inflammation in Down syndrome mouse model

NCAM2 protein is a vital factor in the formation of cerebral cortex, neuronal morphogenesis

NCAM2 protein is a vital factor in the formation of cerebral cortex, neuronal morphogenesis

NTHU research team develops new treatment for Parkinson’s disease

NTHU research team develops new treatment for Parkinson’s disease

No evidence of a link between surgery with anesthesia and Alzheimer's disease

No evidence of a link between surgery with anesthesia and Alzheimer's disease

BIN1 deficit leads to impaired spatial learning and memory

BIN1 deficit leads to impaired spatial learning and memory

New approach to stimulate immune cells may provide better protection against Alzheimer's

New approach to stimulate immune cells may provide better protection against Alzheimer's

Stress-linked disorders increase the risk of later brain degeneration

Stress-linked disorders increase the risk of later brain degeneration

Scientists create new tool to study the genetic underpinnings of brain disorders

Scientists create new tool to study the genetic underpinnings of brain disorders

Study: Distraction by technology during mealtimes may reduce food intake

Study: Distraction by technology during mealtimes may reduce food intake

Researchers find link between interferon, neuroinflammation and synapse loss in Alzheimer's

Researchers find link between interferon, neuroinflammation and synapse loss in Alzheimer's

Research shows how Chlamydia pathogen invades human cells

Research shows how Chlamydia pathogen invades human cells

Researchers uncover novel neurotransmitter system in the brain

Researchers uncover novel neurotransmitter system in the brain

City Of Hope builds cloud-based data commons platform for observational study

City Of Hope builds cloud-based data commons platform for observational study

Curcumin can be delivered effectively into cells via tiny nanoparticles

Curcumin can be delivered effectively into cells via tiny nanoparticles

Norwegian national center receives NOK 22.5 million for the fight against Alzheimer's disease

Norwegian national center receives NOK 22.5 million for the fight against Alzheimer's disease

Nearly $4 million to fund drug discovery research for Alzheimer's, other dementia

Nearly $4 million to fund drug discovery research for Alzheimer's, other dementia

Supplying nutritional amino acid restores spatial memory in mouse model of Alzheimer's

Supplying nutritional amino acid restores spatial memory in mouse model of Alzheimer's

KAIST researchers reveal new strategy to alter neurotoxicity in Alzheimer's disease

KAIST researchers reveal new strategy to alter neurotoxicity in Alzheimer's disease

Alzheimer's could be detected early using a blood test

Alzheimer's could be detected early using a blood test

New blood test could be deployed in primary care setting for people with memory issues

New blood test could be deployed in primary care setting for people with memory issues